Akbarzadeh M, Naderi T, Dabbaghmaneh M, Tabatabaee H, Zareh Z. Investigating Risk Factors for Cardiovascular Disease Based on Polycystic Ovary Syndrome phenotypes in the 18-14 year Old High School Girls in Shiraz 2009. JSSU 2012; 20 (2) :176-86
URL:
http://jssu.ssu.ac.ir/article-1-1977-en.html
Abstract: (10034 Views)
Introduction: In patients with polycystic ovary syndrome hyperinsulinaemia, insulin resistance, dyslipidemia and hyperglycemia may represent an increased risk for coronary cardiovascular disease .This study aimed to investigate risk factors for cardiovascular disease based on polycystic ovary syndrome phenotypes in Shiraz.
Methods: This Cross-sectional study was performed on 3200 students aged 18-14. Demographic survey, clinical signs of androgen excess (acne, hirsutism, alopecia), Ultrasound were applied in order to find the cyst. Tests included prolactin, dehydroepiandrodion sulfate, and oral glucose tolerance test, fasting blood glucose, blood sugar two hours later, triglycerides, cholesterol, high density lipoprotein. Data were submitted to SPSS software, version 11.5 and then analyzed by chi-square tests.
Results: The serum cholesterol mean in four phenotypes had a statistically significant relationship with non-PCOS patients(p<0.05). Mean of serum cholesterol in oligomenorrhea, Hyperandrogenism and polycystic ovary phenotype (195.09±30.28) was higher than the other phenotypes. Mean of serum cholesterol and low density lipoprotein(LDL-C) were significantly higher in patients with Hyperandrogenism and polycystic ovarian phenotype(130.046±26.27) and oligomenorrhea, Hyperandrogenism and polycystic ovary syndrome phenotype(138.58±28.34) compared with non-infected individuals. Serum glucose mean in all phenotype was higher than non-infected after two hours and it showed a significant relation in oligomenorrhea and also polycystic ovarian phenotype(98.03 ± 20.98 versus 87.5±12.97) with non-infected individuals.
Conclusion: Biochemical factors that lead to increased risk of cardiovascular diseases is increased in patients with polycystic ovary syndrome. Therefore, it should be attended in prevention programs
Type of Study:
Original article |
Subject:
General Received: 2012/07/1 | Published: 2012/06/15